Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
rabies mRNA vaccine
- Development stage
- Preclinical
- Lead developer
- AIM Vaccine Co.
- Modality
- mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The rabies mRNA vaccine is an investigational mRNA-based prophylactic vaccine being developed by AIM Vaccine Co., Ltd. to induce protective immune responses against the rabies virus. As part of AIM's broader mRNA technology platform, this candidate is designed to instruct host cells to express rabies virus antigens, thereby stimulating the production of neutralizing antibodies and activating cellular immunity. This approach represents a next-generation alternative to traditional inactivated rabies vaccines, such as those derived from Vero cells or human diploid cells. The vaccine is currently in the preclinical research stage and is a key component of AIM's comprehensive rabies vaccine portfolio.
- Other names
- mRNA rabies vaccineAIM Vaccine rabies mRNA vaccine
02
Targets
RABV-G (Rabies virus glycoprotein)TLR4 (Toll-like receptor 4)
Beyond the preview
Go deeper on rabies mRNA vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on rabies mRNA vaccine.